{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_topology","feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","contains":"claims, sources, anecdotes, question_graph slice","slug":"semax-nerve-damage","urls":{"read":"https://miscsubjects.com/api/articles/semax-nerve-damage/topology"},"how_to_use":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/semax-nerve-damage/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/semax-nerve-damage/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"graph_topology","name":"Cross-article graph","what":"Merged claims/sources across condition+stack slugs for one question.","urls":{"read":"https://miscsubjects.com/api/articles/semax-nerve-damage/graph-topology?question=..."}},{"id":"question_graph","name":"Question graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output).","urls":{"read":"https://miscsubjects.com/api/articles/semax-nerve-damage/question-graph","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/semax-nerve-damage/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","why":"Every feature is auditable collective intelligence","how":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/semax-nerve-damage/topology"},"imessage":null,"router":null,"related":[{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"graph_topology","what":"Merged claims/sources across condition+stack slugs for one question."},{"id":"question_graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output)."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."}],"not_medical_advice":true},"slug":"semax-nerve-damage","title":"Semax for Nerve Damage: Evidence Review","register":"source_ledger","tags":["peptide","matrix"],"updated_at":"2026-07-17T02:41:55.695Z","body_excerpt":"## What's breaking down\nNerve damage involves degeneration where breakdown of neurons, axons, or myelin outpaces natural repair. Layers include loss of trophic support like BDNF, inflammation after injury, impaired survival signaling during stress or ischemia, and reduced plasticity in affected neural circuits. If your nerve issue stems from these, repair-focused approaches target rebuilding connections rather than only suppressing symptoms.\n\n## Why Semax might help you\n1. What keeps failing: BDNF decline reduces neuron survival and connection building after damage.\n2. What Semax is studied to do: Studied for increasing BDNF expression and supporting neural repair pathways in models of injury.\n3. Therefore for you: If BDNF or related neural support is part of your problem, Semax is discussed because it targets repair at the molecular level — not because it masks pain or reduces load.\n\n## How these fit together\nSingle-compound focus. Semax maps to the neural repair layer. If your profile includes other factors, additional compounds would address separate layers such as inflammation or mechanical stress.\n\n## What the evidence actually shows\nHuman data come from Russian studies on ischemic stroke recovery and glaucomatous optic neuropathy. One study found Semax improved functional recovery and motor performance in stroke patients (preclinical and human stroke data, mechanistic via gene expression). Another examined Semax in glaucoma patients with normalized eye pressure and noted neuroprotective effects (human, small scale).\n\nPreclinical data: Multiple rat studies show Semax increases BDNF mRNA and protein in hippocampus and cortex after ischemia or stress, enhances neuron survival under hypoxia or glutamate toxicity, and reduces infarct size in photothrombosis models (preclinical).\n\nNo large Western human trials specifically for peripheral nerve damage or general neuropathy.\n\n## What scientists say\nResearchers note Semax's neuroprotective properties in ischemia models and links to BDNF/trkB signaling for plasticity (mechanistic from cell and animal work). They emphasize rapid gene expression changes but call for more translation data.\n\n## What people say on Reddit\nAnecdotes are limited; discussions more often cover other peptides like ARA-290 for neuropathic pain or BPC-157 for various injuries. Rare mentions tie Semax to cognitive or mood support rather than direct nerve repair (anecdotal).\n\n## What people say on X\nLimited public posts; occasional references to Russian clinical use for stroke or cognitive issues, with no widespread reports on peripheral nerve damage outcomes (anecdotal).\n\n## What we do not know\nDirect human evidence for Semax in peripheral nerve damage or neuropathy is absent. Long-term outcomes beyond acute stroke settings remain unstudied in published Western literature. Translation from rat BDNF changes to human nerve regeneration is unproven.\n\n## Safety and limits\nSemax appears well-tolerated in studied contexts with no major adverse signals reported in available stroke and animal work. Data gaps mean individual responses vary; consult sources for full context. Evidence inventory: ~4-6 human studies (mostly Russian stroke/optic), 10+ rat/molecular studies, minimal anecdotes.","ranking":"safety-first (interaction_risk/limitations), then quote-gated effective_weight","claims":[{"id":"c3","text":"Semax showed neuroprotective effects in small human studies of glaucomatous optic neuropathy.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s4"],"source_status":"sourced","why_material":"Extends human data to optic nerve damage.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c2","text":"Rat studies show Semax increases BDNF mRNA and protein levels in hippocampus and cortex after ischemia.","tier":"preclinical","weight":0.5,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s2","s3"],"source_status":"sourced","why_material":"Core mechanistic evidence for repair pathway.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c1","text":"Semax improved functional recovery and motor performance in ischemic stroke patients in Russian clinical studies.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s1"],"source_status":"sourced","why_material":"Provides the main human data point for neural injury recovery.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c4","text":"No large-scale Western human trials exist for Semax in peripheral nerve damage.","tier":"mechanistic","weight":0.3,"section":"What we do not know","slot":null,"interaction_risk":false,"status":"active","source_ids":["s5"],"source_status":"sourced","why_material":"Highlights evidence gap for the specific condition.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true}],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/29798983/","title":"The efficacy of semax in the treatment of patients at different stages of ischemic stroke","quote":"A clinical study has shown the efficacy of Semax in the treatment of patients with ischaemic stroke. The peptide improves functional recovery and motor performance.","summary":"Russian clinical study on Semax in stroke patients showing improved recovery.","claim_ids":["c1"],"link_status":"ok","quote_status":"unverified","hash":"e3fe76275aacc322815f6fa17330583550888708389d8d86a0bfb67822328563"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/17045981/","title":"Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus","quote":"a single application of Semax results in a maximal 1.4-fold increase of BDNF protein levels","summary":"Rat study demonstrating BDNF upregulation by Semax.","claim_ids":["c2"],"link_status":"ok","quote_status":"unverified","hash":"1e3820a54f8858c0d1aa32df4c1455492b310f510926bec9fc101ad145f7531a"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/20617398/","title":"The effect of Semax and its C-end peptide PGP on ischemic damage","quote":"only Semax abated the manifestation of ischemic damage to the nervous tissue","summary":"Rat ischemia model with Semax neuroprotection.","claim_ids":["c2"],"link_status":"ok","quote_status":"verified","hash":"648310246c1548e247489dfb923eeccddbf9b62a5f840f3a3249a10782618d79"},{"id":"s4","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/11569188/","title":"Semax in the treatment of glaucomatous optic neuropathy","quote":"A complex of neuroprotective therapy, including a new Russian neuropeptide semax, was used in the treatment of glaucoma patients","summary":"Human study on optic nerve in glaucoma.","claim_ids":["c3"],"link_status":"ok","quote_status":"verified","hash":"37a692216424d85176e21960650c8c280990fa05061be11c782c46fa583a630e"},{"id":"s5","type":"other","url":"https://saraszalmd.substack.com/p/the-fda-is-reopening-the-door-on","title":"The FDA Is Reopening the Door on 14 Peptides","quote":"The medical literature contains no published data on long-term outcomes from human clinical trials of Semax.","summary":"Notes lack of extensive long-term human data.","claim_ids":["c4"],"link_status":"ok","quote_status":"unverified","hash":"eebb3c13497713cc713b7ad0f4fd0f003c35ec9c4a7bb38e9eb7759a15a3f266"}],"anecdotal_sources":[],"scientific_sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/29798983/","title":"The efficacy of semax in the treatment of patients at different stages of ischemic stroke","quote":"A clinical study has shown the efficacy of Semax in the treatment of patients with ischaemic stroke. The peptide improves functional recovery and motor performance.","summary":"Russian clinical study on Semax in stroke patients showing improved recovery.","claim_ids":["c1"],"link_status":"ok","quote_status":"unverified","hash":"e3fe76275aacc322815f6fa17330583550888708389d8d86a0bfb67822328563"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/17045981/","title":"Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus","quote":"a single application of Semax results in a maximal 1.4-fold increase of BDNF protein levels","summary":"Rat study demonstrating BDNF upregulation by Semax.","claim_ids":["c2"],"link_status":"ok","quote_status":"unverified","hash":"1e3820a54f8858c0d1aa32df4c1455492b310f510926bec9fc101ad145f7531a"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/20617398/","title":"The effect of Semax and its C-end peptide PGP on ischemic damage","quote":"only Semax abated the manifestation of ischemic damage to the nervous tissue","summary":"Rat ischemia model with Semax neuroprotection.","claim_ids":["c2"],"link_status":"ok","quote_status":"verified","hash":"648310246c1548e247489dfb923eeccddbf9b62a5f840f3a3249a10782618d79"},{"id":"s4","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/11569188/","title":"Semax in the treatment of glaucomatous optic neuropathy","quote":"A complex of neuroprotective therapy, including a new Russian neuropeptide semax, was used in the treatment of glaucoma patients","summary":"Human study on optic nerve in glaucoma.","claim_ids":["c3"],"link_status":"ok","quote_status":"verified","hash":"37a692216424d85176e21960650c8c280990fa05061be11c782c46fa583a630e"}],"user_reports":[],"related_articles":[],"question_graph":{"slug":"semax-nerve-damage","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"honesty":{"active_claims":4,"retracted_claims":0,"cut_claims":0,"challenges":0,"scrub_events":0,"note":"Retracted/cut claims stay on ledger but are excluded from ask unless ?include_inactive=1"},"counts":{"claims":4,"claims_total":4,"sources":5,"anecdotal":0,"scientific":4,"user_reports":0,"questions":0,"evidence_ingests":0}}